Patients that have received hematopoietic stem cell transplantation are at increased risk for a myriad of infectious complications including invasive fungal infection (IFI). These patients face high morbidity and mortality due to difficulty in diagnosis, which lead to delayed treatment. Various prophylactic strategies have been proposed in the past. This article reviews evolving guidelines from various professional organizations so as to facilitate optimization of clinical decision.